A phase 2, randomized double-blind safety and pharmacokinetic assessment of respiratory syncytial virus (RSV) prophylaxis with motavizumab and palivizumab administered in the same season

Simple item page
dc.contributor.authorFernández, P.
dc.contributor.authorTrenholme, A.
dc.contributor.authorAbarca Villaseca, Katia
dc.contributor.authorGriffin, M. P.
dc.contributor.authorHultquist, M.
dc.contributor.authorHarris, B.
dc.contributor.authorLosonsky, G. A.
dc.date.accessioned2020-01-28T15:12:21Z
dc.date.available2020-01-28T15:12:21Z
dc.date.issued2010
dc.fuente.origenSpringer
dc.identifier.doi10.1186/1471-2431-10-38
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/28442
dc.identifier.urihttps://doi.org/10.1186/1471-2431-10-38
dc.issue.numeroNo. 1
dc.language.isoen
dc.revistaBMC Pediatricses_ES
dc.subject.ddc610
dc.subject.deweyMedicina y saludes_ES
dc.subject.otherLactantes - Enfermedadeses_ES
dc.subject.otherVirus sincicial respiratorioes_ES
dc.subject.otherPulmones - infeccioneses_ES
dc.titleA phase 2, randomized double-blind safety and pharmacokinetic assessment of respiratory syncytial virus (RSV) prophylaxis with motavizumab and palivizumab administered in the same seasones_ES
dc.typeartículo
dc.volumenVol. 10
sipa.codpersvinculados70281
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
A phase 2, randomized double-blind safety and pharmacokinetic assessment of respiratory syncytial virus (RSV) prophylaxis with motavizumab.pdf
Size:
678.19 KB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Artículos de revistas